SINGAPORE - Media OutReach Newswire - 23 January 2025 - A groundbreaking study has revealed that INDIBA Proionic 448kHz + 20kHz technology significantly promotes the proliferation of Mesenchymal Stem ...

FDA approved Ryoncil ® as the first and only therapy for pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), ...

Stem cell therapy has come a long way since its early days. As an athlete who has undergone it twice, I know that the ...

A platform that emulates human marrow's native environment has helped researchers to recreate human marrow's complexity.

Hidden within our bones, marrow sustains life by producing billions of blood cells daily, from oxygen-carrying red cells to immune-boosting white cells.

Other testing showed that the new serum—a lightweight formula with small oil-filled beads that burst as you ...

Did this biotech company deliver the goods for investors? Let's see what a $1,000 investment would be worth. The post $1,000 ...

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

Key Insights Stem's significant retail investors ownership suggests that the key decisions are influenced by... SAN FRANCISCO, January 16, 2025--Stem, Inc. (NYSE: STEM), a global leader in ...

Department of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing, China ...

A woman with heart failure was kept alive long enough to receive a heart transplant, in part thanks to newly developed ...